Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
561.43
+24.92 (4.64%)
At close: May 12, 2025, 4:00 PM
560.51
-0.92 (-0.16%)
After-hours: May 12, 2025, 7:40 PM EDT
Intuitive Surgical Revenue
Intuitive Surgical had revenue of $2.25B in the quarter ending March 31, 2025, with 19.19% growth. This brings the company's revenue in the last twelve months to $8.71B, up 19.08% year-over-year. In the year 2024, Intuitive Surgical had annual revenue of $8.35B with 17.24% growth.
Revenue (ttm)
$8.71B
Revenue Growth
+19.08%
P/S Ratio
21.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
201.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.35B | 1.23B | 17.24% |
Dec 31, 2023 | 7.12B | 901.90M | 14.49% |
Dec 31, 2022 | 6.22B | 512.10M | 8.97% |
Dec 31, 2021 | 5.71B | 1.35B | 31.01% |
Dec 31, 2020 | 4.36B | -120.10M | -2.68% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ISRG News
- 6 days ago - Stock Picks From Seeking Alpha's April 2025 New Analysts - Seeking Alpha
- 11 days ago - Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection - GlobeNewsWire
- 13 days ago - Baron Health Care Fund Q1 2025 Top Net Purchases And Sales - Seeking Alpha
- 13 days ago - Baron Health Care Fund Q1 2025 Top Contributors And Detractors - Seeking Alpha
- 17 days ago - Intuitive Surgical: Decent Results But Waiting For An Entry Point - Seeking Alpha
- 19 days ago - Analysts Remain Bullish On Intuitive Surgical Despite Macro Uncertainty - Benzinga
- 19 days ago - These Analysts Lower Their Forecasts On Intuitive Surgical After Q1 Earnings - Benzinga
- 19 days ago - Intuitive Surgical Stock Is Surging. Tariffs Could Be Less of a Threat. - Barrons